HAL (France)
open access
Fédération France Macula Practical Guidelines for the Use of Anti-VEGF Biosimilars
Purpose The introduction of biosimilars for anti-vascular endothelial growth factor (anti-VEGF) represents a challenging shift in the management of retinal diseases requiring long-term intravitreal therapy. While regulatory approval has been supported by robust biosimilarity programs, important prac
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Analysis of the therapeutic effects of anti-vascular endothelial growth factor treatment based on indocyanine green angiographic staining patterns in patients with central serous chorioretinopathy.#284992
- Sym004 in Metastatic Colorectal Cancer and ECD-EGFR Patients#827072
- Refractive Error and Biometry in Retinopathy of Prematurity#1161545
- Clonamiento, expresión y caracterización de la isoforma 121 del factor de crecimiento del endotelio vascular humano (VEGF-A121).#400793
- Evaluation of the changes of anterior segment biometry and intraocular pressure in patients treated with intravitreal injection of antivascular endothelial growth factors#290282
Record · ID 1312595
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive